Keystone Symposium on antimicrobials and resistance
Don’t miss the Keystone Symposium “Antimicrobials and Resistance: Opportunities and Challenges” to be held Oct. 29 through Nov. 1 in Santa Fe, N.M.
Antimicrobial-resistant infections claim hundreds of thousands of lives around the globe annually. This problem is exacerbated by a steady increase in global antimicrobial use and abuse in the clinic and agriculture and a dearth of novel antimicrobials making it to market. If these scenarios continue unchecked, AMR will cumulatively cost the global economy at least $100 trillion by 2050.
This conference focuses on the latest work understanding and combating AMR, including clinical perspectives on AMR diagnostics and management, translational academic perspectives on design of drug regimens and combinations that suppress AMR, pharma perspectives on recent successes and failures in novel antimicrobial development and clinical trials, and basic science perspectives on the ecology and transmission of evolving AMR determinants.
While these stakeholders are similarly motivated to identify and develop therapies to treat the exceptional, unmet medical need of worsening AMR, their spheres rarely overlap at scientific conferences, leading to communication barriers between subject matter experts. This conference attempts to address this challenge by engaging diverse global perspectives on these topics, including speakers and attendees from academic research, industrial drug development, and healthcare practice and policy.
Scientific organizers: Gautam Dantas of the Washington University School of Medicine and Jennifer A. Leeds of the Novartis Institutes for BioMedical Research
Scholarship application and discounted abstract deadline: June 27, 2017
Abstract deadline: July 27, 2017
Discounted registration deadline: Aug. 29, 2017